Line Plot from Scientific Research

Butyricicoccus sp. AM29 23AC (SGB14991). The y axis shows the expected abundance (represented in centered log ratio coordinates) for each study visit ( x axis). Left: anti-PD-1 monotherapy. Right: anti-PD-1/anti-CTLA-4 combination therapy. The corresponding inset figures show the average difference between patients with PFS 12 and PFS <12 months at each study visit, including its 90% credible interval. The number ( n ) represents the number of patient samples at each visit for patients with PFS 12 and PFS <12 months.

DOI